rapid.tech 3D

My Account

Language

Axenoll 3D Printing GmbH

Axenoll 3D Printing GmbH

Short description

Specializing in gentle and efficient 3D screen printing, our patented technology provides additive production and economic solutions for life sciences products and much more. We offer R&D consulting, OEM production and our own products, including biomaterials and living cells.

Contact

Followers

M
1 Following
Show all

Tags

Description

Axenoll is an innovative company specialized in 3D screen printing with expertise in paste development, product design, production, and process optimization. Our potential applications include microfluidic chipswound dressings and cosmetic products. With our gentle technology we perform bioprinting featuring materials containing viable cells. Axenoll owns the worldwide licence for the patented 3D mass customization®-technology, enabling the serial production of reproducible, high resolution items by additive manufacturing. Therefore, our 3D screen printing technology is the only rapid and gentle industrial mass production approach for biomedical and life science applications.

3D screen printing - Strengths

  • Modular construction allows uncomplicated up-scaling ("mass customization")
    and straightforward integration of additional functional units
  • Material combinations and fine (< 20 µm) to coarse structures within one item
  • Different geometries and sizes within one batch
  • Low temperature range and no need for toxic (caustic) chemicals or solvents
  • Low energy input required
  • Incorporation of thermolabile/ chemolabile materials or additives, e.g. cells or peptides

Axenoll is the versatile and adaptable partner for your vision, R&D and products. We offer customer-specific product and process development for the medical, life sciences and cosmetics market, from the idea to serial production.

Axenoll is located within the Pharmapark in the science city Jena. As the city hosts a great number of renowned research institutions, innovative start-ups as well as the Friedrich Schiller university together with the university hospital, we are in an ideal environment for versatile cooperations and joint projects. Besides, we established a diverse network of industrial and academic partners on an (inter)national level.

Paste and product development

We develop and optimize pastes for 3D screen printing according to customer specifications and application specific product requirements, like biocompatibility. Paste properties are modified by additives and product layout, screen parameters and printing setup are adjusted to the paste. Our technology enables the use of a wide range of materials and their combinations, among them biomaterials, biopolymers, synthetic & thermoplastic polymers, viable cells, ceramics, metals and silicones.

Screen design and printing

Our in-house screen design and production enables quick adoption to product design changes, offering flexibility at low costs. Screens, made from materials like PET or VA steel, can be customized based on paste and product characteristics, adjusting parameters like mesh width, thread thickness, and quantity. Photo-polymers for coating are also adaptable to suit the product. If needed, stencils can replace screens, broadening production options. In addition, we can print on different substrates, including glass, paper, metals or fabric.

3D screen printers

Paste, product and process development are performed on our R&D development machine. Environmental parameters, such as temperature and humidity, are adjusted to meet paste and product specifications. Stabilization of printed layers is achieved e.g. by IR or UV radiation. The printers' modular building system allows for easy modifications and expansions, facilitating the integration of additional functional units, such as a plasma source. Our in-house inline machine enables straightforward and rapid upscaling, pro-cessing 10-20 substrate plates in parallel.

Location

Axenoll 3D Printing GmbH

Jena, Germany
Otto-Schott-Strasse 15

Contact

Lutz Freiwald

Lutz Freiwald

Managing Director
Write message